Register
Login:
Share:
Email Facebook Twitter




Quick Poll
QUICK POLL >
Would you use a professional standard news service? (Giving you breaking news sooner)




VAL Share Chat - RSS Feed

Valirx Share Chat (VAL)



Share Price: 0.20Bid: 0.19Ask: 0.21Change: 0.00 (0.00%)No Movement on Valirx
Spread: 0.02Spread as %: 10.53%Open: 0.205High: 0.205Low: 0.195Yesterday’s Close: 0.20


Share Discussion for Valirx (VAL)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


cheers
Posts: 1,825
Off Topic
Opinion:No Opinion
Price:0.20
shares
17 Mar '15
Maybe cut took shares because they can see patients are getting better and expecting significant returns on their investments. Imho
 
darthveder
Posts: 69
Off Topic
Opinion:No Opinion
Price:0.20
Visainn
17 Mar '15
The price would have been agreed on a few weeks ago when the sp was actually .26
Loopylo
Posts: 49
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.20
View Thread (2)
RE: Visainn
17 Mar '15
Hi mm the rns says they agreed the price in 2010
MaidenMitch
Posts: 643
Off Topic
Opinion:No Opinion
Price:0.20
View Thread (2)
Visainn
17 Mar '15
Erm worth NOW £57k. They could have took the £80k and bought even more shares on the open market. Maybe VAL couldn't afford the cash? That wouldn't be good..
Visainn
Posts: 1,015
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.20
They won't sell their new shares
17 Mar '15
They had a contract that they could receive 80k. Why then accept shares at 30 percent ABOVE current SP. Thereby worth NOW 77 thousand approx... If only to sell them on open market. That would be a bit foolish as then you would say I'll have the 80 k please

So inside confirmation here that both parties know the success and progress and both happy to take shares at 30 percent over current sp on basis f future results that are now very close indeed.

Let's see if market agrees

GLTA
1stTee
Posts: 223
Off Topic
Opinion:No Opinion
Price:0.20
May top up today
17 Mar '15
Todays RNS is good news ahead of the expectant upbeat RNS re VAL201 clinical trials.
MaidenMitch
Posts: 643
Off Topic
Opinion:No Opinion
Price:0.20
darth
17 Mar '15
If they sell at the moment they'll lose around £23k, but it's up to them.
Shai16
Posts: 86
Off Topic
Opinion:No Opinion
Price:0.20
CRT
17 Mar '15
darthveder
Posts: 69
Off Topic
Opinion:No Opinion
Price:0.20
Crt
17 Mar '15
Do you think CRT will keep the shares or sell them?
I suppose we will never know.
Cacher
Posts: 3,390
Off Topic
Opinion:No Opinion
Price:0.20
Proactive article
17 Mar '15
Drug developer ValiRx (LON:VAL) has paid £80,000 to Cancer Research Technology after lead drug VAL201 passed first patient dosing in its ongoing phase/II trial.

CRT took the milestone payment in shares at an equivalent price of 0.26p.

ValiRx announced last month that the VAL201 was safe and well tolerated at the doses tested in the trial, which is on patients suffering locally advanced or metastatic prostate cancer and other advanced solid tumours.

Satu Vainikka, chief executive, said the milestone payment was both a vindication of recent progress and, by CRT taking shares, a substantial vote of confidence in ValiRx's future prospects.





Sign up for Live Prices


Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.